EUVIMEDEUVIMED entdecken
Crossref

Mid-term Combination Immunotherapy and its Effect on the Albumin–Bilirubin Score in Unresectable Hepatocellular Carcinoma

Akifumi Kuwano, Masayoshi Yada, Kosuke Tanaka, Junro Takahira, Hideo Suzuki, Kenta Motomura

Anticancer Research · 2025

DOI: 10.21873/anticanres.17552 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Akifumi Kuwano und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatology, Aso Iizuka Hospital, Iizuka, Japan; akuwanoh1@aih-net.com. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Bilirubin, Antineoplastic Combined Chemotherapy Protocols.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsBilirubinAntineoplastic Combined Chemotherapy ProtocolsImmunotherapyHumansMaleFemaleMiddle AgedAgedRetrospective StudiesAntibodies, Monoclonal, HumanizedBevacizumabAntibodies, MonoclonalTreatment OutcomeSerum Albumin, HumanLiver Function Tests

Stichwörter der Autor:innen

Hepatocellular carcinomaalbumin–bilirubin scoreatezolizumab plus bevacizumabtremelimumab plus durvalumab

Substanzen

BilirubinAntibodies, Monoclonal, HumanizedBevacizumabatezolizumabtremelimumabdurvalumabAntibodies, MonoclonalSerum Albumin, Humanalbumin-bilirubin complex

Autor:innen und Institutionen

  • Department of Hepatology, Aso Iizuka Hospital, Iizuka, Japan; akuwanoh1@aih-net.com.
  • Department of Hepatology, Aso Iizuka Hospital, Iizuka, Japan.
  • Department of Gastroenterology, Ichinomiyanishi Hospital, Ichinomiya, Japan.

Zitieren

APA

Kuwano, A., Yada, M., Tanaka, K., Takahira, J., Suzuki, H., & Motomura, K. (2025). Mid-term Combination Immunotherapy and its Effect on the Albumin–Bilirubin Score in Unresectable Hepatocellular Carcinoma. Anticancer Research. https://doi.org/10.21873/anticanres.17552

Vancouver

Kuwano A, Yada M, Tanaka K, Takahira J, Suzuki H, Motomura K. Mid-term Combination Immunotherapy and its Effect on the Albumin–Bilirubin Score in Unresectable Hepatocellular Carcinoma. Anticancer Research. 2025. doi:10.21873/anticanres.17552

BibTeX
@article{Kuwano2025,
  author = {Kuwano, Akifumi and Yada, Masayoshi and Tanaka, Kosuke and Takahira, Junro and Suzuki, Hideo and Motomura, Kenta},
  title = {Mid-term Combination Immunotherapy and its Effect on the Albumin–Bilirubin Score in Unresectable Hepatocellular Carcinoma},
  journal = {Anticancer Research},
  year = {2025},
  doi = {10.21873/anticanres.17552}
}
Kostenlos starten →